Southern medical journalHumansAntibodiesMonoclonalHumanizedFemale
Safety Profile of Using Tocilizumab in the Treatment of Severely Ill Patients with COVID-19.
Michael J Schnaus, Thomas E Schmidt, Kate Schmiechen, Nicole D Garrett, Elie Gertner
Published: 202510.14423/SMJ.0000000000001905
Abstract
OBJECTIVES: Tocilizumab, originally used in the treatment of autoimmune disorders such as rheumatoid arthritis, had its use expanded to treat hyperinflammatory changes in coronavirus disease 2019. The objective of this study was to evaluate the risk…
Preview only. Read the full abstract at the source